#pharmaceutical-competition

[ follow ]
#gsk #share-price #corporate-restructuring #patent-rights #drug-prices #intellectual-property #c4ip #novo-nordisk
Business
fromwww.theguardian.com
21 hours ago

GSK, take two: the bullish tone at the top is finally more convincing | Nils Pratley

GSK's share price returned to its post-merger level after 25 years, indicating cautious investor optimism amid restructuring and leadership-driven changes.
Startup companies
fromFast Company
8 months ago

Novo Nordisk announces CEO transition as share price slips

Novo Nordisk's CEO Lars Fruergaard Jorgensen is stepping down amid market challenges despite leading the company through significant growth in the weight-loss drug sector.
[ Load more ]